BNP Paribas Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6K Sell
647
-379
-37% -$10.5K ﹤0.01% 2073
2026
Q1
$19.2K Buy
1,026
+437
+74% +$8.34K ﹤0.01% 2046
2025
Q4
$14K Buy
+589
New +$15.2K ﹤0.01% 2057
2025
Q3
Sell
-424
Closed -$7K 2061
2025
Q2
$7K Buy
+424
New +$7.47K ﹤0.01% 1903
2016
Q1
Sell
-340,617
Closed -$2.43M 1085
2015
Q4
$2.43M Sell
340,617
-7,096
-2% -$57.5K 0.02% 622
2015
Q3
$2.7M Sell
347,713
-77,840
-18% -$641K 0.02% 606
2015
Q2
$4.11M Sell
425,553
-53,454
-11% -$496K 0.03% 550
2015
Q1
$3.56M Buy
+479,007
New +$3.5M 0.03% 573

Other funds holding STAA

BNP Paribas Asset Management's STAA Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its STAAR Surgical (STAA) stake by 37% in Q2 2026, selling an estimated $10.5K and leaving 647 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

BNP Paribas Asset Management first reported a position in STAA in Q1 2015 and has held it in 8 quarters since. The position peaked at $4.11M in Q2 2015. 201 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • BNP Paribas Asset Management held 647 shares of STAAR Surgical worth $18.6K as of Q2 2026.
  • BNP Paribas Asset Management sold 379 STAAR Surgical shares in Q2 2026, an estimated $10.5K.
  • STAAR Surgical made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2073 holding.
  • BNP Paribas Asset Management first reported a position in STAAR Surgical in Q1 2015 and has held it in 8 quarters since.
  • BNP Paribas Asset Management's STAAR Surgical position peaked at $4.11M in Q2 2015.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.